All Categories chevron icon Search

Decision Insights™ Acute Care EHR Commentary

Subject Expert
Tyson Blauer
Insights Director
KLAS Insights Director - Tyson Blauer
Return to Decisions  Show Filters
Step 13 of

Interview Timeframe

Step 14 of
Within Months: [0 - 24]
24
0
 
Step 12 of
Step 18 of

Step 1 of
Related ReportsView All Reports
Performance
KLAS article icon
UK & Ireland EPR 2024
09 July 24    |   Eder Lagemann and Spencer Corbett
Over the last five years, there has been consistent energy around EPR investment and digital transformation in the UK and Ireland—on average, at least six healthcare organisations have made an EPR purchase decision each year. Going forward, activity will likely increase amid integrated care system (ICS) alignment, as over 50 trusts will look to upgrade or deploy their first EPR over the next few years. While going through the complex decision-making process, organisations frequently look for a partner that can provide not only core documentation and ordering functionalities but also additional clinical, administrative and ancillary modules to support their digital transformation. This report includes (1) an overview of the market share and customer satisfaction with EPR suppliers in the UK and Ireland and (2) a look at suppliers’ broader portfolios, diving into the performance and adoption of modules outside of core functionality.
Market Share
KLAS article icon
US Acute Care EHR Market Share 2024
17 May 24    |   Paul Warburton and Tyson Blauer
Acute care EHR purchasing remained high throughout 2023. While market energy in 2022 was mostly driven by small organizations, the majority of 2023 purchases were the result of large multispecialty and specialty organizations making go-forward decisions. Of the 319 hospitals impacted by go-forward decisions (including migrations and specialty hospital wins), 79% were part of health systems while the remainder were standalone hospitals. Key decision drivers were acquisition activity and the need to streamline IT departments and improve clinical usability. This report examines these and other trends in EHR purchases that occurred in the US from January–December 2023.
Performance
KLAS article icon
Oracle Health (Cerner) Complete Look 2023
18 July 23    |   Paul Warburton and Tyson Blauer
When making a core HIT purchasing decision, healthcare organizations must take into account how prospective partners deliver across a variety of key technology areas. This Oracle Health (Cerner) “complete look” provides a high-level analysis of the key products that make up Oracle Health’s enterprise suite. (Other reports in the series do the same for Altera Digital Health [Allscripts] , Epic , Evident , and MEDITECH .)
Performance
KLAS article icon
Epic Complete Look 2023
18 July 23    |   Paul Warburton and Tyson Blauer
When making a core HIT purchasing decision, healthcare organizations must take into account how prospective partners deliver across a variety of key technology areas. This Epic “complete look” provides a high-level analysis of the key products that make up Epic’s enterprise suite. (Other reports in the series do the same for Altera Digital Health [Allscripts] , Evident , MEDITECH , and Oracle Health [Cerner] .)
Performance
KLAS article icon
Altera Digital Health (Allscripts) Complete Look 2023
18 July 23    |   Paul Warburton and Tyson Blauer
When making a core HIT purchasing decision, healthcare organizations must take into account how prospective partners deliver across a variety of key technology areas. This Altera Digital Health (Allscripts) Sunrise “complete look” provides a high-level analysis of the key products that make up Altera Digital Health’s enterprise suite. (Other reports in the series do the same for Epic , Evident , MEDITECH , and Oracle Health [Cerner] .) This report focuses on the core Sunrise suite and its supporting technology; data on Altera Digital Health’s standalone ambulatory platforms (TouchWorks and Professional) is excluded.
Performance
KLAS article icon
Evident Complete Look 2023
18 July 23    |   Paul Warburton and Tyson Blauer
When making a core HIT purchasing decision, healthcare organizations must take into account how prospective partners deliver across a variety of key technology areas. This Evident (CPSI) “complete look” provides a high-level analysis of the key products that make up Evident’s core enterprise suite and its supporting technology. (Other reports in the series do the same for Altera Digital Health [Allscripts] , Epic , MEDITECH , and Oracle Health [Cerner] .)
Performance
KLAS article icon
MEDITECH Complete Look 2023
18 July 23    |   Paul Warburton and Tyson Blauer
When making a core HIT purchasing decision, healthcare organizations must take into account how prospective partners deliver across a variety of key technology areas. This MEDITECH Expanse “complete look” provides a high-level analysis of the key products that make up MEDITECH’s enterprise suite. (Other reports in the series do the same for Altera Digital Health [Allscripts] , Epic , Evident , and Oracle Health [Cerner] .) This report focuses on the core Expanse suite; data on MEDITECH’s MAGIC, C/S, and 6.x platforms is excluded.
White Paper
KLAS article icon
Hallmarks of High-Performing Companies 2023
10 May 23    |   Emily Paxman
HIT vendors consistently strive to live up to their customers’ expectations, and KLAS data shows that most vendors successfully keep all their promises. But in the last year, one in four healthcare organizations interviewed by KLAS report their vendor does not keep all promises. This report highlights where broken promises most often occur, the impact of broken promises on provider organizations, and how both organizations and vendors can ensure promises are kept, fostering better vendor/client trust and ultimately better patient care.


Subject Expert
Tyson Blauer
Insights Director
KLAS Insights Director - Tyson Blauer



We use cookies! We use essential and basic aggregated, depersonalized Google Analytics cookies to provide the type of content which our visitors are most interested in.  Cookie Policy    
​